HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells

被引:123
作者
Muthumani, K
Hwang, DS
Desai, BM
Zhang, DH
Dayes, N
Green, DR
Weiner, DB
机构
[1] Univ Penn, Dept Pathol & Lab Med, Stellar Chance Labs 505, Philadelphia, PA 19104 USA
[2] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
[3] Viral Genomix, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M205313200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus, type 1 (HIV-1), vpr gene encodes a 14-kDa virion-associated protein, which exhibits significant effects on human cells. One important property of Vpr is its ability to induce apoptosis during infection. Apoptotic induction is likely to play a role in the pathogenesis of AIDS. However, the pathway of apoptosis is not clearly defined. In this report we investigate the mechanism of apoptosis induced by HIV-1 Vpr using a Vpr pseudotype viral infection system or adeno delivery of Vpr in primary human lymphoid cells and T-cells. With either vector, HIV-1 Vpr induced cell cycle arrest at the G(2)/M phase and apoptosis in lymphoid target cells. Furthermore, we observed that with both vectors, caspase 9, but not caspase 8, was activated following infection of human peripheral blood mononuclear cell with either Vpr-positive HIV virions or adeno-delivered Vpr. Activation of the caspase 9 pathway resulted in caspase 3 activation and apoptosis in human primary cells. These effects were coincident with the disruption of the mitochondrial transmembrane potential and induction of cytochrome c release by Vpr. The Vpr-induced signaling pathway did not induce CD95 or CD95L expression. Bcl-2 overexpressing cells succumb to Vpr-induced apoptosis. These studies illustrate that Vpr induces a mitochondria-dependent apoptotic pathway that is distinct from apoptosis driven by the Fas-FasL pathway.
引用
收藏
页码:37820 / 37831
页数:12
相关论文
共 46 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[3]  
BOON B, 1998, SCIENCE, V281, P266
[4]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[6]   High throughput method for creating and screening recombinant adenoviruses [J].
Davis, AR ;
Meyers, K ;
Wilson, JM .
GENE THERAPY, 1998, 5 (08) :1148-1152
[7]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[8]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[9]   HIV-1, Vpr and the cell cycle [J].
Emerman, M .
CURRENT BIOLOGY, 1996, 6 (09) :1096-1103
[10]   HIV-1 Vpr increases viral expression by manipulation of the cell cycle:: A mechanism for selection of Vpr in vivo [J].
Goh, WC ;
Rogel, ME ;
Kinsey, CM ;
Michael, SF ;
Fultz, PN ;
Nowak, MA ;
Hahn, BH ;
Emerman, M .
NATURE MEDICINE, 1998, 4 (01) :65-71